Intec Pharma Expands Intellectual Property With a New Patent for the Accordion Pill in Europe
JERUSALEM, ISRAEL -- (Marketwired) -- 10/22/15 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that the …